Re: Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence From an International Randomized Trial of Everolimus-Based Immunosuppression.
Re: Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence From an International Randomized Trial of Everolimus-Based Immunosuppression.
Ann Transplant. 2019 Mar 29;24:174
Authors: Saliba F, Fischer L, de Simone P, Bernhardt P, Bader G, Fung J
Abstract
Ann Transplant. 2018 Oct 26;23:751-757. doi: 10.12659/AOT.911030. PMID: 30361470, PMCID: PMC6248043 In the paper, the sentence on page 754, first column, lines 4, 5, and 6 has been incorrectly written: At the month 24 study visit, mean (SD) eGFR was 74.7 (26.1), 67.8 (21.0), and 77.5 (26.2) mL/min/1.73 m2 in the EVR/rTAC, TAC Elimination, and TAC Control groups, respectively (p=0.007). The corrected sentence should read: At the 24-month study visit, mean (SD) eGFR was 74.7 (26.1), 67.8 (21.0), and 77.5 (26.2) mL/min/1.73 m2 in the EVR/rTAC, TAC Control, and TAC Elimination groups, respectively (p=0.007).
PMID: 30923305 [PubMed - in process]
Source: Annals of Transplantation - Category: Transplant Surgery Authors: Saliba F, Fischer L, de Simone P, Bernhardt P, Bader G, Fung J Tags: Ann Transplant Source Type: research
More News: Liver | Liver Transplant | Study | Transplant Surgery | Transplants | Urology & Nephrology